By
Latest Stories
Don’t miss our hot and upcoming stories
How Merck’s $3B MoonLake Acquisition the AI-Powered Bet That Will Reignite Late-Phase Biotech and Immune-Driven Precision Trials?
Key Highlights Merck Moves Decisively: A $3 Billion Signal to the Late-Stage Biotech MarketMerck has…
Can HekaBio and Alfresa’s AI-Driven Alliance Redefine Japan’s Biopharma Access and Launch Asia’s Next AI Commercialization Engine?
Smart Partnerships: HekaBio Leverages Alfresa’s Scale to Localize Global InnovationJapan’s historically delayed access to global…
China focus: Is AstraZeneca’s $5.3B AI-Powered Alliance with CSPC the New Gold Standard in Chronic Disease Drug Discovery?
Key Takeaways: AI as the Catalyst: CSPC’s Dual-Engine Platform Front and CenterAt the core of…
Can Ellipsis Health’s $45M Series A and Launch of ‘Sage’ Redefine AI-Driven Care Management in U.S. Healthcare?
Key Insights: Sage Redefines AI Care Management with Empathy at the CoreEllipsis Health is introducing…